News

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs, while LifeMD is a direct-to-patient telehealth company that provides a cost-effective ...
Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1. Under the deal, cash-paying patients can access a month's supply ...
LifeMD does accept some insurance plans for medication, though this varies depending on the provider and medication. The LifeMD Weight Management Program does not include the cost of medication.
(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative ...
LifeMD will participate in three investor conferences in May, offering presentations and meetings with investors. Quiver AI Summary LifeMD, Inc. announced its participation in several investor ...
LifeMD announced it will offer access to Wegovy through Novocare Pharmacy. The company will offer the weight-loss drug at a reduced self-pay price of $499 per month. 3 Summer "Power Patterns" Are ...
LifeMD's growth accelerates with expanded insurance, new health products, and a 43% revenue boost. Click here to read our most recent analysis of LFMD.
LifeMD Inc (LFMD) reported a robust financial performance for the fourth quarter of 2024, significantly surpassing market expectations with an earnings per share (EPS) of $0.21 against a ...